✦ LIBER ✦

Randomised Phase II study of topotecan/cisplatin versus topotecan/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ Scribed by Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley, A; Ross, G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Cisplatin–etoposide alternating with top

✍ Mavroudis, D; Veslemes, M; Kouroussis, Ch; Tzanakis, N; Ferdoutsis, E; Toumbis, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 97 KB

P-558 Phase-II trial of topotecan and et

✍ Reck, Martin; Buchholz, Erika; Groth, Gesine; Kaubitzsch, Sabine; Gatzemeier, Ul 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

The sequential administration of cisplat

✍ D. Mavroudis; S. Agelaki; Ph. Palamidas; Ch. Kouroussis; A. Harpidou; M. Toubis; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

P-563 Phase I study of sequential topote

✍ Miller, Antonius A.; Tucker, Robert; Lesser, Glenn; Case, Doug 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Sequential administration of cisplatin–e

✍ Mavroudis, D; Pavlakou, G; Blazoyiannakis, G; Veslemes, M; Apostolopoulou, F; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB